For the Inventor, By the Inventor

Enter assignee name

Novato, CA, United States of America

Raptor Pharmaceuticals Inc.

USPTO Granted Patents = 12

% Expired Patents = 58.3

CIPO Patents = 2

EPO Patents = 2

Trademarks = 1

Forward Citations = 84

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Christopher M Starr (5 out of 19 patents)

Todd C Zankel (5 out of 16 patents)

Kathlene Powell (3 out of 4 patents)

4. Ramesh Muttavarapu (3 out of 4 patents)

5. Thomas E Daley (2 out of 3 patents)

6. Michael N Dudley (1 out of 36 patents)

7. Mark William Surber (1 out of 37 patents)

8. Olga Rodny (1 out of 27 patents)

9. David C Griffith (1 out of 36 patents)

10. Michel Demeule (1 out of 21 patents)

11. Keith A Bostian (1 out of 17 patents)

12. Elizabeth C Squiers (1 out of 5 patents)

13. Kin-Hung Peony Yu (1 out of 1 patent)

14. Kathy Powell (1 out of 1 patent)

15. Olga Jarzebinski (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 9435785 - Methods for analyzing cysteamine compositions (2016-09-06),

2. 9326971 - 4-methylpyrazole formulations for inhibiting ethanol intolerance (2016-05-03),

3. 9326936 - Aerosol fluoroquinolone formulations for improved pharmacokinetics (2016-05-03),

4. 9233077 - Delayed release cysteamine bead formulation, and methods of making and using same (2016-01-12),

5. 9173851 - Delayed release cysteamine bead formulation, and methods of making and using same (2015-11-03),

6. 9173850 - 4-methylpyrazole formulations (2015-11-03),

7. 9062126 - Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof (2015-06-23),

8. 8795627 - Treatment of liver disorders by administration of RAP conjugates (2014-08-05),

9. 8609103 - Megalin-based delivery of therapeutic compounds to the brain and other tissues (2013-12-17),

10. 8440629 - Cyclic receptor-associated protein (RAP) peptides (2013-05-14),

11. 7829537 - Receptor associated protein (RAP) conjugates (2010-11-09),

12. 7700554 - Compositions for modulating blood-brain barrier transport (2010-04-20),

Raptor Pharmaceuticals Inc., based in Novato, California, is a biopharmaceutical company focused on developing innovative therapies for rare diseases. The company specializes in the research and development of treatments that address unmet medical needs, particularly in the areas of metabolic and genetic disorders. Raptor's commitment to advancing healthcare solutions is reflected in its dedication to scientific excellence and collaboration with the medical community to improve patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#7 in Novato, CA

#6,060 in California

#25,540 in US

#48,129 in the World

Novato, CA, United States of America

Raptor Pharmaceuticals Inc.

Forward Citations = 84

19 inventors:

Christopher M Starr (5 out of 19 patents)

Todd C Zankel (5 out of 16 patents)

Kathlene Powell (3 out of 4 patents)

4. Ramesh Muttavarapu (3 out of 4 patents)

5. Thomas E Daley (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…